Nystagmus, Congenital Idiopathic

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Nystagmus, Congenital Idiopathic trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…

United States, Australia20,000 participantsStarted 2010-07

All recent trials (3 shown)

TerminatedPhase 2

NCT00799942

Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus

The purpose of this study is to investigate the long-term safety, tolerability and efficacy of neramexane mesylate in the treatment of congenital idiopathic nys…

United Kingdom48 participantsStarted 2009-05

Treatment: Neramexane mesylate

CompletedPhase 2

NCT00661440

Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of congenital idiopathic nystagmus (CIN) in comparis…

United Kingdom48 participantsStarted 2008-05

Treatment: Neramexane mesylate